Islet Sciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Islet Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10689
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company’s pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflammation. It offers cell therapy based artificial pancreas for the treatment of type 1 diabetes. Islet Sciences provides a PCR based molecular diagnostic test measuring hypomethylated beta cell-derived DNA as a biomarker of beta cell loss for the early detection of the onset of type 1 diabetes or insulin dependent type 2 diabetes. The company also develops ßinfusion technology, a vialed suspension of microencapsulated porcine islets for injection into the abdominal cavity. Islet Sciences is headquartered in Santa Monica, California, the US.

Islet Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Islet Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Islet Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Islet Sciences Raises USD0.03 Million in Financing Round 11
Islet Sciences Raises Additional USD1.5 Million in Venture Financing 12
Islet Sciences Raises US$0.7 Million In Venture Financing 13
Islet Sciences Raises Additional USD2.8 Million in Venture Financing 14
Islet Sciences Raises US$1.4 Million In Venture Financing 15
Partnerships 16
Islet Sciences Enters Into Agreement With Spring Point Project 16
Licensing Agreements 17
Islet Sciences Enters into Licensing Agreement with Brighthaven Ventures for Remogliflozin Etabonate 17
Islet Sciences Enters Into Licensing Agreement With University of California 18
Islet Sciences Enters Into Licensing Agreement With Winthrop-University Hospital For Beta Cell Loss Measurement Technology 19
Acquisition 20
Islet Sciences Completes Acquisition Of DiaKine Therapeutics, Diabetes Drug Maker 20
Islet Sciences Inc – Key Competitors 21
Islet Sciences Inc – Key Employees 22
Islet Sciences Inc – Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Islet Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Islet Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Islet Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Islet Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Islet Sciences Raises USD0.03 Million in Financing Round 11
Islet Sciences Raises Additional USD1.5 Million in Venture Financing 12
Islet Sciences Raises US$0.7 Million In Venture Financing 13
Islet Sciences Raises Additional USD2.8 Million in Venture Financing 14
Islet Sciences Raises US$1.4 Million In Venture Financing 15
Islet Sciences Enters Into Agreement With Spring Point Project 16
Islet Sciences Enters into Licensing Agreement with Brighthaven Ventures for Remogliflozin Etabonate 17
Islet Sciences Enters Into Licensing Agreement With University of California 18
Islet Sciences Enters Into Licensing Agreement With Winthrop-University Hospital For Beta Cell Loss Measurement Technology 19
Islet Sciences Completes Acquisition Of DiaKine Therapeutics, Diabetes Drug Maker 20
Islet Sciences Inc, Key Competitors 21
Islet Sciences Inc, Key Employees 22

List of Figures
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Islet Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Islet Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Islet Sciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AIB Group (UK) plc:企業の戦略的SWOT分析
    AIB Group (UK) plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Centre for Commercialization of Regenerative Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is an healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, bio materials and devices manufacturing. The center’s cell reprogramming and engineering offers various capabilities such as esta …
  • Yasuhara Chemical Co Ltd (4957):企業の財務・戦略的SWOT分析
    Yasuhara Chemical Co Ltd (4957) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • OUTsurance Holdings Limited:企業の戦略・SWOT・財務情報
    OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Matrix IT Ltd (MTRX):企業の財務・戦略的SWOT分析
    Matrix IT Ltd (MTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Graphic Packaging Holding Company:戦略・SWOT・企業財務分析
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Galderma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions s …
  • Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報
    Summary Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provide …
  • SymBio Pharmaceuticals Ltd (4582):製薬・医療:M&Aディール及び事業提携情報
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. The company develops SyB drugs, treakisym and rigosertib, among others. It offers business development services in areas of oncology, hematology and pain-management areas …
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • Public Power Corporation S.A.:企業の戦略・SWOT・財務情報
    Public Power Corporation S.A. - Strategy, SWOT and Corporate Finance Report Summary Public Power Corporation S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Center For Diagnostic Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Center For Diagnostic Imaging Inc (CDI), a subsidiary of InSight Health Services Holdings Corp is a healthcare center that patient care services. The center offers upright MRI, diagnostic breast imaging exams, breast biopsies, open CDI vascular care, open upright MRI, nuclear medicine, ultra …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sobha Ltd:企業の戦略・SWOT・財務情報
    Sobha Ltd - Strategy, SWOT and Corporate Finance Report Summary Sobha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Sanofi SA:企業のM&A・事業提携・投資動向
    Sanofi SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sanofi SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Press Association:企業の戦略・SWOT・財務情報
    Press Association - Strategy, SWOT and Corporate Finance Report Summary Press Association - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Electricity Supply Board:電力:M&Aディール及び事業提携情報
    Summary Electricity Supply Board (ESB) owned by Irish Government, is a diversified and vertically integrated utility that generates, transmits, and distributes and supplies electricity and gas. The company builds, owns and maintains transmission and distribution networks. It offers meter reading, an …
  • Western Gas Equity Partners LP:企業の戦略・SWOT・財務情報
    Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report Summary Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Frisch’s Restaurants, Inc.:戦略・SWOT・企業財務分析
    Frisch's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary Frisch's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pardus Oil & Gas LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Pardus Oil & Gas LLC (Pardus Oil & Gas), formerly Energy & Exploration Partners LLC, is an oil and gas exploration and development company that acquires, explores, develops and produces onshore unconventional oil and natural gas assets in East Texas. The company operates oil and liquids-rich …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆